Talk:Antibody-vaccine engineered construct
Latest comment: 7 years ago by Marek Malecki MD
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | This article references a source that one of the article's contributors wrote or published. Citing oneself is allowed on Wikipedia, but may represent a conflict of interest. Contributors should be careful not to place undue weight on their own work, and are discouraged from excessive self-citation. Guidelines relevant to this situation include Wikipedia:Conflict of interest, Wikipedia:Neutral point of view and WP:SELFPUBLISHED.
|
Marek Malecki MD (talk) 04:39, 1 May 2017 (UTC)
- ^ Malecki M, Sabo C, Foorohar A, Tombokan X. Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B. Clinical and Translational Medicine. 2016;5:32. doi:10.1186/s40169-016-0111-8. PMC 4990520.